by Mark S. King | Aug 9, 2019 | My Fabulous Disease, News, Prevention and Policy
There is a lot to unpack about this week’s FDA Advisory Panel hearing on Gilead’s new cash cow option for pre-exposure prophylaxis (PrEP), Descovy. I want to point you to the coverage that best suits you, including terrific reporting from an Australian radio show (!)... 
by Mark S. King | Jun 20, 2019 | Gay Life, Living with HIV/AIDS, My Fabulous Disease, News, Prevention and Policy
When Toronto drag queen Jade Elektra, aka HIV positive activist Alphonso King, Jr., stepped to the stage of the 2019 Toronto AIDS Vigil on Tuesday night, she knew she had a message. It wasn’t simply that she would become the first drag performer to sing live at the... 
by Mark S. King | May 17, 2019 | Gay Life, Living with HIV/AIDS, My Fabulous Disease, News, Prevention and Policy, Trump
On Thursday, May 16, 2019, the House Oversight Committee conducted a hearing to try and get to the bottom of the Truvada pricing and patent scandal. They were not messing around. The title of the hearing was, “HIV Prevention Drug: Billions in Corporate Profits after... 
by Mark S. King | May 10, 2019 | Living with HIV/AIDS, My Fabulous Disease, News, Prevention and Policy, Trump
Gilead Sciences, the pharmaceutical that makes Truvada, the only FDA-approved drug for PrEP, is having a great week in the public relations department. First, Gilead announced they were surrendering their patent for Truvada a year early, and now Federal... 
by Mark S. King | Apr 29, 2019 | My Fabulous Disease, News, Prevention and Policy
My first job in AIDS in the 1980s was at the Los Angeles Shanti Foundation, an organization that provided companions for the dying. When our founding director, Daniel P. Warner, retired from the organization, the final candidates for his job met with the full staff...
